Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -165008.70x is 998% below its 3-year average of -15021.38x, near the low end of its 3-year range (-165008.70x–-3.99x).
As of the fiscal period ended Monday, September 30, 2019. 299.84% below its 12-month average of -41268.93x.
Reported quarterly interest coverage; no daily interpolation. Q3 FY2019 (2019-09-30): -165008.70x.
INTEREST COVERAGE RATIO
-165008.70x
INTEREST COVERAGE RATIO AVG TTM
-41268.93x
INTEREST COVERAGE RATIO AVG 3Y
-18357.62x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-299.84%
CURRENT VS 3Y AVG
-798.86%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.54x
median of 430 covered companies
CURRENT VS SECTOR MEDIAN
-2978396.39%
vs the sector median at left
Co-Diagnostics, Inc.
Market Cap
$7.13M
Interest Coverage Ratio
-165008.70x
TTM Avg
-41268.93x
3Y Avg
-18357.62x
5Y Avg
N/A
Market Cap
$6.98M
Interest Coverage Ratio
-185.05x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.26M
Interest Coverage Ratio
-496.55x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.01M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.31M
Interest Coverage Ratio
-924.78x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.58M
Interest Coverage Ratio
-82777.81x
TTM Avg
11.97x
3Y Avg
11.97x
5Y Avg
11.97x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Co-Diagnostics, Inc. (CODX) | $7.13M | -165008.70x | -41268.93x | -18357.62x | N/A |
| Mangoceuticals, Inc. (MGRX)vs › | $6.98M | -185.05x | N/A | N/A | N/A |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.26M | -496.55x | N/A | N/A | N/A |
| NeuroSense Therapeutics Ltd. (NRSN)vs › | $7.01M | N/A | N/A | N/A | N/A |
| KALA BIO, Inc. (KALA)vs › | $7.28M | -11.95x | N/A | N/A | N/A |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.31M | -924.78x | N/A | N/A | N/A |
| Longeveron Inc. (LGVN)vs › | $7.47M | N/A | N/A | N/A | N/A |
| Aclarion, Inc. (ACON)vs › | $6.66M | N/A | N/A | N/A | N/A |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.58M | -82777.81x | 11.97x | 11.97x | 11.97x |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.90M | N/A | N/A | N/A | N/A |
Interest Coverage
-165008.7x
Debt/Equity
0.14
Current Ratio
1.81
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2019-09-30 | -165008.70x |
| 2019-03-31 | -11.79x |
| 2018-12-31 | -21.18x |
| 2018-09-30 | -34.05x |
| 2017-09-30 | -121.96x |
| 2017-06-30 | -4.55x |
| 2017-03-31 | -3.99x |
| 2016-12-31 | -5.51x |
| 2016-09-30 | -6.81x |
| 2016-06-30 | -7.46x |
| 2016-03-31 | -9.20x |
